Advocacy intelligence hub — real-time data for patient organizations
Shanghai United Cell Biotechnology Co., Ltd — PHASE4
BDH-Klinik Hessisch Oldendorf
Shandong Suncadia Medicine Co., Ltd. — PHASE1
Xuanzhu Biopharmaceutical Co., Ltd. — PHASE4
Second Affiliated Hospital, School of Medicine, Zhejiang University — PHASE2
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. — PHASE3
Minia University — NA
Pfizer — PHASE1
Sun Yat-sen University — PHASE2
Chipscreen Biosciences, Ltd. — PHASE1, PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Yuankai Shi
Chinese Academy of Medical Sciences
Use Central Contact
Astellas Pharma Inc
Benjamin Philosophe, MD, PHD, M.D
Johns Hopkins University
📍 BALTIMORE, MD
Mohamed Al-Ibrahim
Pharmaron CPC, Inc.
📍 BALTIMORE, MD
Mohamed Al-Ibrahim, MD
SNBL
📍 BALTIMORE, MD
Ning Li, MD
Department of Generay Surgery, Jinling hosptal, Medical School of Nanjing University
View all Catastrophic antiphospholipid syndrome specialists →